(Q53184112)
Statements
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence. (English)
Steven E Lipshultz
Endel John Orav
Stuart R Lipsitz
1 July 2007
25
21
3179; author reply 3180